Development and validation of an individualized immune prognostic model in stage I–III lung squamous...
Development and validation of an individualized immune prognostic model in stage I–III lung squamous cell carcinoma
About this item
Full title
Author / Creator
Yang, Qi-Fan , Wu, Di , Wang, Jian , Ba, Li , Tian, Chen , Liu, Yu-Ting , Hu, Yue and Liu, Li
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Lung squamous cell carcinoma (LUSC) possesses a poor prognosis even for stages I–III resected patients. Reliable prognostic biomarkers that can stratify and predict clinical outcomes for stage I–III resected LUSC patients are urgently needed. Based on gene expression of LUSC tissue samples from five public datasets, consisting of 687 cases, we deve...
Alternative Titles
Full title
Development and validation of an individualized immune prognostic model in stage I–III lung squamous cell carcinoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e3d3131177f044b8a16fa6a095441956
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e3d3131177f044b8a16fa6a095441956
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-021-92115-0
